Rare diseases
Investigational molecules
Locations
Pocernicka 1427/16, Strasnice, 100 00 Prague, Czechia
Clintrial s.r.o. in Prague, Czechia specialises in clinical trials of conditions such as Dermatitis atopic, Major depression, Psoriasis, Migraine, and other specialisations. This site conducts important research.
The medical center is at the forefront of dermatology research, focusing on innovative treatments for skin conditions such as atopic dermatitis and plaque psoriasis. Through extensive clinical trials, the center evaluates the safety and efficacy of novel therapies, aiming to improve patient outcomes and quality of life.
By exploring new therapeutic agents and delivery methods, the center contributes significantly to the advancement of dermatological care.
Specializing in psychiatry, the medical center conducts pioneering research on mental health disorders, including schizophrenia and major depressive disorder (MDD). The focus is on developing adjunctive therapies that enhance the effectiveness of existing treatments, providing hope for patients with inadequate responses to standard care.
Through rigorous clinical trials, the center aims to uncover new insights into the pathophysiology of these conditions, paving the way for more personalized and effective treatment strategies.
The center is a leader in rheumatology research, particularly in the treatment of rheumatoid arthritis. By comparing biosimilars and reference products, the center seeks to provide cost-effective and accessible treatment options for patients suffering from this chronic inflammatory disorder.
Research efforts are directed towards understanding the immunogenicity and long-term safety of these therapies, ensuring that patients receive the most effective care possible.
In the field of neurology, the medical center is dedicated to advancing the treatment of Alzheimer's disease and cognitive impairments associated with schizophrenia. By evaluating new pharmacological interventions, the center aims to slow disease progression and improve cognitive function in affected individuals.
The center's research contributes to a deeper understanding of neurodegenerative processes, offering hope for more effective management of these challenging conditions.
Clinical trials currently enrolling participants at this site.
Long-Term Safety and Efficacy of Zasocitinib in Adults with Active Psoriatic Arthritis
CzechiaLong-term safety study of deucravacitinib compared to ustekinumab in adults with moderate to severe plaque psoriasis
CzechiaLong-term safety study of oral povorcitinib in patients with hidradenitis suppurativa, prurigo nodularis, or vitiligo who previously participated in clinical trials
CzechiaStudy of evenamide as add-on treatment for patients with treatment-resistant schizophrenia not adequately controlled by current antipsychotic medications
CzechiaLong-term safety and effectiveness study of APG777 injection in patients with moderate-to-severe atopic dermatitis who previously received APG777 treatment
CzechiaStudy on ITI-1284 for Patients with Generalized Anxiety Disorder Who Did Not Respond Well to Previous Treatments
CzechiaStudy of Zasocitinib and Apremilast for Adults with Active Psoriatic Arthritis Who Have Not Used Biologic Medicines
CzechiaStudy on Seltorexant for Adults and Elderly with Major Depressive Disorder and Insomnia Symptoms
CzechiaStudy of Camoteskimab and Sodium Chloride Placebo in Adults with Moderate-to-Severe Atopic Dermatitis
CzechiaA study to evaluate the effectiveness and safety of DT-101 in adults with major depressive disorder
CzechiaA Study of SPT-300 Compared to Placebo for Adults with Major Depressive Disorder with or without Anxious Distress
CzechiaA Study of Brexanolone Caprilcerbate for Adults with Major Depressive Disorder With or Without Anxious Distress
CzechiaMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
